Preliminary results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma Meeting Abstract
| Authors: | Herrera, A. F.; Bartlett, N. L.; Ramchandren, R.; Vose, J. M.; Moskowitz, A. J.; Feldman, T. A.; LaCasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; Kato, K.; Fong, A.; Advani, R. H. |
| Abstract Title: | Preliminary results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Start Page: | 1105 |
| Language: | English |
| ACCESSION: | WOS:000394446803139 |
| DOI: | 10.1182/blood.V128.22.1105.1105 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 624 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
